Einträge von Velicki, Lazar auf dem Publikationsserver

Fuller, Amy S., Okwose, Nduka C, Charman, Sarah J., Voppel, Alban E., Stefanetti, Renae J., Groenewegen, Amy, Del Franco, Annamaria, Tafelmeier, Maria , Preveden, Andrej, Milovancev, Aleksandra, Edwards, Duncan, Nelissen, Anne P., Barlocco, Fausto, Fornaro, Alessandra, Zamorano, Jose Luis, Milli, Massimo, Sasso, Laura, Taborchi, Giulia, Bartolini, Simone, Fatucchi, Serena, Banerjee, Prithwish, MacGowan, Guy A., Fernandez, Oscar, Bravo, Marta Jimenez-Blanco, Maier, Lars S. , Olivotto, Iacopo, Rutten, Frans H., Mant, Jonathan, Velicki, Lazar , Seferović, Petar M., Filipovic, Nenad und Jakovljevic, Djordje G. (2026) Voice recognition as an innovative method to identify and monitor heart failure – a review. Heart Failure Reviews 31 (1).

Georgoula, Marina, Kotoulas, Grigorios G., Tsarapatsani, Konstantina-Helen, Boucharas, Dimitrios G., Kyprakis, Ioannis, Manousos, Dimitrios, Preveden, Andrej, Velicki, Lazar , Groenewegen, Amy, Rutten, Frans, Flis, Borut, Pičulin, Matej, Vračar, Peter, Bosnić, Zoran, Tafelmeier, Maria , Maier, Lars S. , Barlocco, Fausto, Olivotto, Iacopo, Jimenez-Blanco, Marta, Zamorano, Jose Luis, Edwards, Duncan, Banerjee, Prithwish, Okwose, Nduka C., Charman, Sarah, Jakovljevic, Djordje G. , Tsiknakis, Manolis und Fotiadis, Dimitrios I. (2025) A Multidimensional Framework for Data Quality Assessment in Heart Failure: Integrating IEEE 2801-2022 and Fairness Metrics. In: 2025 IEEE 25th International Conference on Bioinformatics and Bioengineering (BIBE), 06-08 November 2025, Athens, Greece. Volltext nicht vorhanden.

Darbà, Josep, Ascanio, Meritxell, Rodríguez, Antonio, Charman, Sarah J., Okwose, Nduka C., Stefanetti, Renae J., Groenewegen, Amy, Del Franco, Annamaria, Tafelmeier, Maria , Preveden, Andrej, Fuller, Amy S., Bano, Fatima, Sinclair, David R., Edwards, Duncan, Nelissen, Anne P., Malitas, Petros N., Zisaki, Aikaterini, Bosnić, Zoran, Vračar, Petar, Fornaro, Alessandra, Barlocco, Fausto, Fotiadis, Dimitris, Banerjee, Prithwish, MacGowan, Guy A., Fernandez, Oscar, Zamorano, José Luis, Jimenez-Blanco Bravo, Marta, Maier, Lars S. , Olivotto, Iacopo, Milli, Massimo, Rutten, Frans H., Mant, Jonathan, Velicki, Lazar, Seferovic, Petar M., Filipovic, Nenad und Jakovljevic, Djordje G. (2025) Economic Burden of Heart Failure in Europe: A Systematic Review of Costs and Cost-Effectiveness. ESC Heart Failure 12 (6), S. 4055-4068.

Charman, Sarah Jane, Okwose, Nduka C., Groenewegen, Amy, Del Franco, Annamaria, Tafelmeier, Maria , Preveden, Andrej, Garcia Sebastian, Cristina, Fuller, Amy S., Sinclair, David R., Edwards, Duncan, Nelissen, Anne Pauline, Malitas, Petros N., Zisaki, Aikaterini, Darbà, Josep, Bosnić, Zoran, Vracar, Petar, Barlocco, Fausto, Fotiadis, Dimitris, Banerjee, Prithwish, MacGowan, Guy A., Fernandez, Oscar, Zamorano, José, Jiménez-Blanco Bravo, Marta, Maier, Lars S. , Olivotto, Iacopo, Rutten, Frans H., Mant, Jonathan, Velicki, Lazar , Seferovic, Petar M., Filipovic, Nenad und Jakovljevic, Djordje G. (2025) Clinical validation of an artificial intelligence-based decision support system for diagnosis and risk stratification of heart failure (STRATIFYHF): a protocol for a prospective, multicentre longitudinal study. BMJ Open 15 (1), e091793.

Velicki, Lazar, Popovic, Dejana, Okwose, Nduka C., Preveden, Andrej, Tesic, Milorad, Tafelmeier, Maria , Charman, Sarah J., Barlocco, Fausto, MacGowan, Guy A., Seferovic, Petar M., Filipovic, Nenad, Ristic, Arsen, Olivotto, Iacopo, Maier, Lars S. und Jakovljevic, Djordje G. (2024) Sacubitril/Valsartan for the Treatment of Non-Obstructive Hypertrophic Cardiomyopathy: An Open Label Randomized Controlled Trial (SILICOFCM). European Journal of Heart Failure 26 (6), S. 1361-1368.

Pičulin, Matej , Smole, Tim, Žunkovič, Bojan, Kokalj, Enja , Robnik-Šikonja, Marko, Kukar, Matjaž , Fotiadis, Dimitrios I. , Pezoulas, Vasileios C. , Tachos, Nikolaos S. , Barlocco, Fausto, Mazzarotto, Francesco , Popović, Dejana, Maier, Lars S. , Velicki, Lazar , Olivotto, Iacopo, MacGowan, Guy A., Jakovljević, Djordje G. , Filipović, Nenad und Bosnić, Zoran (2022) Disease Progression of Hypertrophic Cardiomyopathy: Modeling Using Machine Learning. JMIR Medical Informatics 10 (2), e30483.

Preveden, Andrej , Golubovic, Miodrag, Bjelobrk, Marija , Miljkovic, Tatjana, Ilic, Aleksandra, Stojsic, Snezana, Gajic, Dragan, Glavaski, Mila , Maier, Lars S. , Okwose, Nduka , Popovic, Dejana, Barlocco, Fausto, Ristic, Arsen , MacGowan, Guy A., Olivotto, Iacopo, Filipovic, Nenad, Jakovljevic, Djordje G. und Velicki, Lazar (2022) Gender Related Differences in the Clinical Presentation of Hypertrophic Cardiomyopathy—An Analysis from the SILICOFCM Database. Medicina 58 (2), S. 314.

Smole, Tim, Žunkovič, Bojan, Pičulin, Matej, Kokalj, Enja, Robnik-Šikonja, Marko, Kukar, Matjaž, Fotiadis, Dimitrios I., Pezoulas, Vasileios C., Tachos, Nikolaos S. , Barlocco, Fausto, Mazzarotto, Francesco , Popović, Dejana, Maier, Lars, Velicki, Lazar , MacGowan, Guy A., Olivotto, Iacopo , Filipović, Nenad, Jakovljević, Djordje G. und Bosnić, Zoran (2021) A machine learning-based risk stratification model for ventricular tachycardia and heart failure in hypertrophic cardiomyopathy. Computers in Biology and Medicine 135, S. 104648. Volltext nicht vorhanden.

Tafelmeier, Maria , Baessler, Andrea, Wagner, Stefan, Unsöld, Bernhard, Preveden, Andrej, Barlocco, Fausto, Tomberli, Alessia, Popovic, Dejana, Brennan, Paul, MacGowan, Guy A., Ristic, Arsen, Velicki, Lazar , Olivotto, Iacopo, Jakovljevic, Djordje G. und Maier, Lars S. (2020) Design of the SILICOFCM study: Effect of sacubitril/valsartan vs lifestyle intervention on functional capacity in patients with hypertrophic cardiomyopathy. Clinical Cardiology 43 (5), S. 430-440.

Velicki, Lazar , Jakovljevic, Djordje G. , Preveden, Andrej, Golubovic, Miodrag, Bjelobrk, Marija, Ilic, Aleksandra, Stojsic, Snezana, Barlocco, Fausto, Tafelmeier, Maria, Okwose, Nduka, Tesic, Milorad, Brennan, Paul, Popovic, Dejana, Ristic, Arsen, MacGowan, Guy A., Filipovic, Nenad, Maier, Lars S. und Olivotto, Iacopo (2020) Genetic determinants of clinical phenotype in hypertrophic cardiomyopathy. BMC Cardiovascular Disorders 20 (1). Volltext nicht vorhanden.